Merck & Co Inc (NYSE:MRK)
| 90.97 Delayed Data As of Jan 17 |  -0.21 / -0.23%Today’s Change | 72.05 Today|||52-Week Range 92.64 | +0.02% Year-to-Date |
Latest MRK News | Press Releases
| Here's Why Clovis Oncology Rose as Much as 25.6% Today Jan 15 / MotleyFool.com - Paid Partner Content | The Risk of Cancer-Related Death Is Dropping Faster Than Ever Jan 08 / MotleyFool.com - Paid Partner Content |
| FDA Gives Clovis Oncology's Rubraca a Priority Review Jan 15 / MotleyFool.com - Paid Partner Content | Dollar Tree Stock Is Down 20%, But Investors Should Reject Mini-Tender Offer Jan 08 / MotleyFool.com - Paid Partner Content |
| Better Buy: Johnson & Johnson vs. Merck Jan 15 / MotleyFool.com - Paid Partner Content | Merck's Keytruda Misses an Important Lung Cancer Goal Jan 07 / MotleyFool.com - Paid Partner Content |
| Merck's Blockbuster Drug Wins Key New FDA Approval Jan 08 / MotleyFool.com - Paid Partner Content |
